- Posts: 206
- Thank you received: 9
1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!
We removed Cyclosporine A and remain promacta last year, but the platelet count crashed after 1.5 months.DeeDee Marie wrote: Hi Dr. Bean,
You are doing very well! It might not be a good idea to stop the Cyclosporine A and reduce
the promacta at the same time. Is this what you did before? Maybe try one at a time and see how you respond. Good luck to you! And, hopefully you will not crash this time.
Dee Dee
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Dee Dee, thanks.DeeDee Marie wrote: Hi Dr. Bean!
With a platelet count of 189, you are doing great! It seems you are presently holding
steady, and I am so glad to hear this. Your doctor seems to have the right treatment for
your case, which is really good.
Thanks for checking in and updating us! And, hoping your platelets stay up there!
Dee Dee
Rob, thank you.Rob16 wrote: Hi Dr. Bean,
I don't often reply, but I am always glad to see your updates. Looking good!
Thanks.mrsb04 wrote: Dr Bean
Nice count..is the reduction in cyclosporin continuing?
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
www.bloodjournal.org/content/120/21/1095
Cyclosporine-Romiplostim-IVIG Combination Therapy in Refractory ITP
Emily Leven, Allison Miller, Brittany Cooper, James B Bussel
Blood 2012 120:1095;
Conclusions: These results suggest that cyclosporine can be used as part of an effective combination with romiplostim and IVIG to manage patients with difficult ITP. The 3 agents were chosen to target different mechanisms of disease pathobiology: FcR “blockade” (IVIG), stimulation of platelet production (TPO-A) and inhibition of T cell activation (CSA). The efficacy of added CSA suggests that activated T cells contribute to refractoriness in difficult ITP.
onlinelibrary.wiley.com/doi/10.1111/jcpt.12421/full
Journal of Clinical Pharmacy and Therapeutics
Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature review
Authors: A. Rashidi MD PhD, M. A. Blinder MD First published: 8 July 2016 DOI: 10.1111/jcpt.12421
"Combination immunosuppression can potentiate the effect of TPO-RAs. This mechanistically reasonable strategy could result in a more rapid response than the more popular, sequential, single-agent strategy. Stepwise tapering can be successfully implemented. Comparing sequential single-agent therapy with early combination approach warrants a more extensive study."
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.
Platelet Disorder Support Association
8751 Brecksville Road, Suite 150, Cleveland, Ohio 44141
Phone: 1-87-PLATELET | 877-528-3538 (toll free) | or 440-746-9003
E-mail: pdsa@pdsa.org
© Copyright 1997 - 2024, Platelet Disorder Support Association. All rights reserved.
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.